Information Provided By:
Fly News Breaks for December 19, 2019
Dec 19, 2019 | 06:33 EDT
BofA/Merrill analyst Michael Ryskin upgraded Elanco (ELAN) to Buy from Neutral. The analyst notes that while other animal health companies like Zoetis (ZTS) and IDEXX (IDXX) outperformed the S&P500, Elanco suffered with an 11% year-to-date decline on broadly negative initial one-off reaction to the Bayer animal health business acquisition.
News For ELAN;BAYRY;ZTS;IDXX From the Last 2 Days
There are no results for your query ELAN;BAYRY;ZTS;IDXX